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Abstract
Objective: The outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in octogenarians and nonagenarians have received limited study.
Methods: We compared in-hospital outcomes of CTO PCI between patients
≥80 vs. <80-years-old in 6233 CTO PCIs performed between 2012 and 2020 at
33 U.S. and international centers.
Results: There were 415 octogenarians and nonagenarians in our study (7% of
the total population). Compared with younger patients, octo- and nonagenarians were less likely to be men (73% vs. 83.2%, p < 0.0001) and more likely to
have atrial fibrillation (27% vs. 12%, p < 0.0001) and prior coronary artery
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bypass graft surgery (CABG) (43% vs. 29%, p < 0.0001). They were more likely
to have CTOs with moderate/severe calcification (71% vs. 46%, p < 0.0001), but
had similar mean J-CTO scores (2.5 ± 1.3 vs. 2.4 ± 1.3, p = 0.08). They had
lower technical and procedural success (82.2% vs. 86.3%, p = 0.0201; 80.3% vs.
84.8%, p = 0.016, respectively) and higher incidence of in-hospital major
adverse cardiovascular events (3.4% vs. 1.8%, p = 0.021). On multivariable analysis PCI in octo- and nonagenarians was not independently associated with
technical and procedural success or with in-hospital MACE.
Conclusion: CTO PCI is feasible in octo- and nonagenarians, although success rates are lower, and the risk of complications is higher compared with
younger patients, likely related to more comorbidities and higher coronary
lesion complexity.
KEYWORDS
chronic total occlusion, octogenarians, percutaneous coronary intervention

INTRODUCTION

Key Points

Old age has been associated with worse outcomes
after chronic total occlusion (CTO) percutaneous coronary intervention (PCI). 1,2 The increasing life expectancy along with increasing prevalence of CTOs with
older age,3 raises questions about the risk/benefit
ratio of CTO PCI in older people. We examined CTO
PCI characteristics and in-hospital outcomes in octogenarians and nonagenarians in a multicenter CTO
PCI registry.

• CTO PCI in octogenarians and nonagenarians
is associated with lower technical and procedural success rates and higher in-hospital
MACE rates compared with younger patients.
• These outcomes are likely due to higher prevalence of baseline comorbidities and CTO lesion
complexity.

METHODS
Patient population
We analyzed the frequency, characteristics and inhospital outcomes of CTO PCI performed in octogenarians and nonagenarians vs. younger patients in a
multicenter registry. Data collection was performed
both prospectively and retrospectively and was
recorded in a dedicated online database (PROGRESS
CTO: Prospective Global Registry for the Study of
Chronic Total Occlusion Intervention, clinicaltrials.
gov Identifier: NCT02061436). Study data were collected and managed using REDCap (Research Electronic Data Capture) electronic data capture tools
hosted at Minneapolis Heart Institute Foundation. 4,5
The study was approved by the institutional review
board of each site and a waiver of informed consent
was obtained.

Why Does this Paper Matter?
Octogenarians and nonagenarians represent a
significant proportion of patients that undergo
CTO PCI. Success rates are lower and in-hospital
MACE rates are higher in ≥80-years-old patients,
likely because they have more baseline comorbidities and higher lesion complexity.

Definitions
Coronary CTOs were defined as coronary lesions with
thrombolysis in myocardial infarction grade 0 flow of at
least 3 months duration. Estimation of the duration of
occlusion was clinical, based on the first onset of angina
pectoris, prior history of myocardial infarction in the target vessel territory, or comparison with a prior angiogram. Calcification was assessed by angiography as mild
(spots), moderate (involving ≤50% of the reference lesion

CTO-PCI IN OCTOGENARIANS AND NONAGENARIANS

TABLE 1

3

Baseline characteristics of the study patients classified according to patient age
≥80-years-old
N = 415

<80-years-old
N = 5635

p-value

Men, n (%)

303 (73)

4665 (83.2)

<0.001

BMI (kg/m2)a

27.4 [24.3–30]

30 [26.7–34.2]

<0.001

Ad hoc CTO PCI, n (%)

41 (11)

527 (10)

0.69

CAD presentation

0.36

Acute coronary syndrome, n (%)

108 (28.3)

1303 (24.7)

Stable angina pectoris, n (%)

245 (64.3)

3502 (66.4)

Other, n (%)

28 (7.4)

467 (8.9)

Indication of CTO-PCI

0.0004

Symptom relief, n (%)

240 (69.4)

3282 (68.8)

Acute coronary syndrome, n (%)

36 (10.4)

262 (5.5)

Ischemia reduction, n (%)

29 (8.4)

604 (12.7)

Reduced ejection fraction, n (%)

13 (3.8)

238 (5)

Staged for complete revascularization
stable angina, n (%)

13 (3.8)

250 (5.2)

Other, n (%)

15 (4.3)

137 (2.9)

Smoking

<0.001

Current/recent, n (within 1 year) (%)

20 (5)

1463 (26.9)

Past, n (%)

207 (52)

2057 (37.9)

Never, n (%)

171 (43)

1914 (35)

Atrial fibrillation, n (%)

65 (27)

388 (11.8)

<0.001

Diabetes mellitus, n (%)

152 (37.4)

2341 (42.6)

0.04

Dyslipidemia, n (%)

382 (93.4)

4862 (87.8)

<0.001

Prior valve surgery/procedure, n (%)

24 (6.1)

108 (2)

<0.001

Hypertension, n (%)

383 (94)

4968 (89.8)

<0.001

Prior MI, n (%)

168 (43.1)

2455 (46.3)

0.22

Prior heart failure, n (%)

131 (33)

1577 (29.3)

0.11

Prior CABG, n (%)

174 (43.3)

1586 (28.9)

<0.001

254 (63.8)

3327 (61.1)

0.27

Prior PCI, n (%)
b

50 ± 13

50 ± 13

0.9

Cerebrovascular disease, n (%)

54 (13.3)

543 (10)

0.033

Stress test done within 90 days, n (%)

130 (35.7)

1956 (39.1)

0.19

Positive stress test results, n (%)

122 (93.9)

1751 (92.2)

0.78

Myocardial viability testing performed, n (%)

81 (24)

1413 (31.1)

0.0062

Ejection fraction, n (%)

Viable myocardium at CTO perfused area, n (%)

66 (93%)

1219 (95%)

0.72

Peripheral arterial disease, n (%)

70 (17.3)

761 (14)

0.07

Chronic lung disease, n (%)

67 (16.6)

774 (14.3)

0.2

Anemia, n (%)

104 (39.9)

793 (21.2)

<0.0001

eGFR (1.73 ml/min/m2)b

59 ± 19

73 ± 24

<0.0001

Abbreviations: BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CTO, chronic total occlusion; LVEF, left
ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention.
a
Median [IQR].
b
Mean ± SD.
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diameter), and severe (involving >50% of the reference
lesion diameter). Moderate proximal vessel tortuosity was
defined as the presence of at least two bends >70 or one
bend >90 and severe tortuosity as two bends >90 or
one bend >120 in the CTO vessel. A procedure was
defined as retrograde if an attempt was made to cross the
lesion through a collateral vessel or bypass graft supplying the target vessel distal to the lesion; if not, the procedure was classified as antegrade-only. Antegrade
dissection/reentry was defined as antegrade PCI during
which a guidewire was intentionally introduced into the
sub-intimal space proximal to the lesion, or reentry into
the distal true lumen was attempted after intentional or
inadvertent subintimal guidewire crossing.
Technical success was defined as successful CTO
revascularization with achievement of <30% residual
diameter stenosis within the treated segment and restoration of TIMI grade 3 antegrade flow. Procedural success
was defined as the achievement of technical success without any in-hospital complications. In-hospital major
adverse cardiac events (MACE) included any of the following adverse events prior to hospital discharge: death, myocardial infarction, recurrent symptoms requiring urgent
repeat target vessel revascularization with PCI or coronary
artery bypass graft surgery (CABG), tamponade requiring

TABLE 2

either pericardiocentesis or surgery, and stroke. Myocardial infarction (MI) was defined using the Third Universal
Definition of Myocardial Infarction (type 4a MI).6 The Japanese CTO (J-CTO) score was calculated as described by
Morino et al,7 the PROGRESS-CTO score as described by
Christopoulos et al,8 the PROGRESS-CTO complications
score as described by Danek et al9 and the EuroCTO
(CASTLE) score as described by Szijgyarto et al.10

Statistical analysis
Categorical variables were expressed as percentages and
were compared using Pearson's chi-square test or Fisher's
exact test. Continuous variables were presented as
mean ± SD or median (interquartile range [IQR]) unless
otherwise specified and were compared using the Student's t-test and one-way analysis of variance (ANOVA)
for normally distributed variables and the Wilcoxon
rank-sum test, or the Kruskal–Wallis test for nonparametric continuous variables, as appropriate. No additional analyses were performed to address missing data.
All statistical analyses were performed with JMP 13.0
(SAS Institute, Cary, North Carolina). A p-value of 0.05
was considered statistically significant.

Baseline angiographic characteristics of the study lesions classified according to patient age
≥80-years-old
N = 422

<80-years-old
N = 5811

Target vessel

<0.001

RCA, n (%)

177 (43.5)

2997 (53.4)

LAD, n (%)

147 (36.1)

1406 (25.1)

LCX, n (%)

72 (17.7)

1104 (19.7)

11 (2.7)

104 (1.9)

25 [15, 40]

25 [15, 40]

0.18

Other, n (%)
Lesion length

a
a

3 [2.5–3]

3 [2.5–3]

0.57

Proximal cap ambiguity, n (%)

114 (31.2)

1849 (36.1)

0.06

Interventional collaterals, n (%)

190 (51.9)

2870 (57.4)

0.041

Moderate/severe calcification, n (%)

267 (70.5)

2421 (46)

<0.001

Moderate/severe proximal tortuosity, n (%)

117 (31)

1619 (30.9)

0.98

In-stent restenosis, n (%)

52 (12.9)

887 (16.1)

0.1

b

2.5 ± 1.3

2.4 ± 1.3

0.09

2.9 ± 1.3

1.9 ± 1.3

<0.0001

1.3 ± 1

1.3 ± 1

0.27

4.4 ± 1.2

2.7 ± 1.9

<0.001

Vessel diameter

J-CTO score

b

CASTLE score

PROGRESS-CTO score

b

PROGRESS-CTO complications scoreb
a

Median [IQR].
Mean ± SD.
Abbreviations: CTO, chronic total occlusion; IQR, interquartile range; LAD, left anterior descending; LCX, circumflex; RCA, right coronary artery;
SD, standard deviation.
b

p-value
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Multivariable logistic regression was used to examine
the association between age ≥ 80 years old and technical
success, procedural success and in-hospital MACE after
adjusting for confounding variables selected on
univariable association (p < 0.10). Three separate multivariable analysis models were built based on the aforementioned endpoints.
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octogenarians and 11 were nonagenarians (415 patients:
7% of total population). The baseline characteristics of
the study patients are summarized in Table 1. Compared
with younger patients, octogenarians/nonagenarians
were less likely to be men (73% vs. 83%, p < 0.0001), had
lower median body mass index (BMI) (27 vs.
30, p < 0.0001), and were more likely to have atrial fibrillation (27% vs. 12%, p < 0.001) and prior coronary artery
bypass graft surgery (CABG) (43% vs. 29%, p < 0.001).

RESULTS
Patient characteristics

Angiographic characteristics

Of the 6824 CTO PCIs included in the PROGRESS-CTO
registry, patient age was missing in 581 cases (8.5%) who
were excluded from the analysis. Between 2012 and 2019
6233 CTO PCIs were performed in 6050 patients at 33
U.S. and international centers, of whom 404 were

The baseline angiographic characteristics of the study
CTOs are listed in Table 2. The most common target vessel was the right coronary artery (RCA) (43.5% in the ≥80
group vs. 53.4% in the <80 group, followed by the left
anterior descending artery (LAD) (36.1% in the ≥80

T A B L E 3 Technical aspects of the
study procedures classified according to
patient age

≥80-years-old
N = 422

<80-years-old
N = 5811

p-value

Dual injection, n (%)

246 (68.6)

3428 (68.8)

0.92

Radial access, n (%)

154 (37)

2878 (51)

<0.0001

Femoral access, n (%)

353 (85.1)

4246 (75.4)

<0.0001

AWE, n (%)

355 (84.1)

4938 (84.5)

0.64

ADR, n (%)

101 (23.9)

1418 (24.4)

0.83

Retrograde, n (%)

152 (36)

1855 (31.9)

0.08

Crossing strategies used

First crossing strategy

0.92

AWE, n (%)

333 (81)

4669 (81.3)

ADR, n (%)

20 (4.9)

309 (5.4)

Retrograde, n (%)

55 (13.4)

718 (12.5)

Successful crossing strategy

0.95

AWE, n (%)

214 (51.9)

2981 (52)

ADR, n (%)

59 (14.3)

845 (14.7)

Retrograde, n (%)

78 (18.9)

1113 (19.4)

IVUS use, n (%)

134 (41.4)

1864 (40)

0.64

OCT use, n (%)

9 (3)

84 (2)

0.21

Non-CTO PCI at the same time, n (%)

125 (32)

1326 (25.1)

0.002

Balloon uncrossable lesions, n (%)

53 (16.6)

457 (10.4)

<0.001

Balloon undilatable lesions, n (%)

35 (15)

324 (9.4)

0.006

LVAD use, n (%)

21 (5.8)

209 (4.3)

0.17

Prophylactic, n (%)

13 (61.9)

150 (71.7)

0.34

Urgent, n (%)

9 (42.9)

41 (19.6)

0.0138

347 (82.2)

5013 (86.3)

0.021

Technical success, n (%)

Abbreviations: ADR, antegrade dissection re-entry; AWE, antegrade wire escalation; LVAD, left ventricular
assist device.
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group vs. 25.1% in the <80 group). CTOs in the ≥80
group were more likely to have moderate or severe calcification (71% vs 46%, p < 0.001).

Technical characteristics and procedural
outcomes
The technical aspects of the procedures are summarized in
Table 3. There was no difference in crossing strategies
between the ≥80 year-old-group and < 80-year-old patients.
Non-CTOs were treated at the same time in 32% of patients
in the ≥80 group compared with 25% in the <80 group
(p = 0.018). Octogenarians and nonagenarians were more
likely to have balloon uncrossable (17% vs. 10%, p < 0.001)
and balloon undilatable (15% vs. 9%, p = 0.006) lesions.
Procedural outcomes are summarized in Table 4.
Compared with younger patients octogenarians and
nonagenarians had lower technical success (82% vs. 86%,
p = 0.021) and procedural success (80.3% vs. 84.8%,
p = 0.016) and higher in-hospital MACE (3.4% vs. 1.8%,
p = 0.021). Most in-hospital MACE events were cardiac
tamponade requiring pericardiocentesis (Figure 1A).
Compared with patients aged <80 years old, the
≥80 year-old-group had higher rates of perforation (8.2%
vs. 4.5%, p < 0.001). The ratio of perforations requiring
pericardiocentesis according to age group is shown in
Figure 1B.

TABLE 4

On multivariable analysis, age ≥ 80-years-old was not
associated with procedural success (adjusted odds ratio of
1.15; CI 95%, 0.86–1.54; p = 0.34) (Figure S1A), technical
success (adjusted odds ratio of 1.18; CI 95%, 0.86–1.64;
p = 0.30) (Figure S1B) or in-hospital MACE (adjusted
odds ratio of 1.4 CI 95%, 0.49–4; p = 0.5) (Figure S1C).

DISCUSSION
The main findings of our study are that octo- and nonagenarians represented 7% of consecutive patients in
whom CTO PCI was performed in a multicenter CTO
PCI registry and had lower technical and procedural success rates and higher MACE rates compared with younger patients. On multivariable analysis, however,
age ≥ 80 years, was not associated with lower procedural
or technical success and higher rate of in-hospital
MACE .
The lower CTO PCI success rate in octo- and nonagenarians is likely due to more complex anatomy, such as
greater degree of calcification, a feature that hinders CTO
crossing and increases the risk of complications, such as
perforation. Moreover, operators are likely to stop crossing attempts earlier in very old patients due to fear of
complications.11 Indeed the risk of MACE was nearly
twice higher in the ≥80-year-old group, with higher risk
of perforation, which is consistent with the higher

Procedural outcomes classified according to patient age
≥ 80-years-old
N = 415

<80-years-old
N = 5635

p-value

Procedural success, n (%)

331 (80.3)

4741 (84.8)

0.016

In-hospital MACE, n (%)

14 (3.4)

100 (1.8)

0.021

2 (0.5)

19 (0.3)

0.65

a

133 [84, 196]

116 [75, 171]

<0.001

a

220 [157, 300]

225 [160, 305]

0.08

a

Death, n (%)
Procedure time (min)

Contrast volume (ml)

2.3 [1.2–3.8]

2.4 [1.3–4]

0.18

Fluoroscopy time (min)a

51 [29–77]

43 [26–69]

<0.001

Perforation, n (%)

34 (8.2)

252 (4.5)

<0.001

Patient AK dose (Gy)

Perforation type

0.89

Ellis Class 1, n (%)

6 (25)

37 (18.8)

Ellis Class 2, n (%)

9 (37.5)

80 (40.6)

Ellis Class 3, n (%)

6 (25)

49 (24.9)

Ellis Class 4, n (%)

3 (12.5)

31 (15.7)

Vascular access site complication, n (%)

5 (1.2)

79 (1.4)

0.74

Bleeding, n (%)

4 (1)

42 (0.8)

0.62

Abbreviations: AK, Air Kerma; MACE, major adverse cardiovascular events.
a
Median [IQR].
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F I G U R E 1 (A) In-hospital major adverse cardiovascular events (MACE) after chronic total occlusion (CTO) percutaneous coronary
intervention (PCI) according to age. (B) Perforations and perforations requiring pericardiocentesis after chronic total occlusion (CTO)
percutaneous coronary intervention (PCI) in octo- and nonagenarians

Progress-CTO complications score in this group (4.4
vs. 2.7, p < 0.001). However, most perforations (in both
age groups) were Ellis classes 1 and 2 and did not result
in MACE, a finding similar to the study by Hirai et al.12
Older patients should ideally be treated at high volume,
experienced CTO PCI centers to maximize the likelihood
of success and minimize the risk of complications.13-15
Experienced operators are also more likely to successfully
treat complications should they arise.16,17

Previous studies
Elective PCI performed in octogenarians has been associated with worse outcomes.18 In a previous analysis of the
PROGRESS-CTO registry, Karatasakis et al reported that

higher age (>65) was independently associated with technical failure and in-hospital MACE after CTO PCI.1
Toma et al found no difference in in-hospital MACE after
CTO PCI when comparing older versus younger patients
and successful CTO PCI was independently associated
with better long-term survival in older patients.19 Andre
et al found a similar success rate for CTO-PCI in older
patients (defined as ≥75-years-old) as compared with
younger patients.20 Zhang et al reported that CTO PCI
did not significantly improve long-term clinical outcomes
in older patients (defined as ≥75-years-old).21 Hoebers
et al reported similar success rates for CTO PCI in
patients ≥75-years-old and younger patients and found
that successful revascularization was associated with
lower MACE (composite of mortality, myocardial infarction, or coronary artery bypass graft surgery [CABG]) at

8

5-year follow-up.22 Tanaka et al found no difference in
technical success (77% vs. 79%, p = 0.66) and in-hospital
complications between patients ≥75-years-old and younger patients.23 Patients with successful PCI had significantly higher 3-year cardiac survival (97.6% vs 76.9%,
p = 0.005) compared with patients with failed CTO PCI
attempt. Strengths of our study compared with prior studies include large sample size, especially in the older individuals group and the definition of old as ≥80-years old.

Limitations
Our study has limitations. First, it is an observational,
retrospective study with all inherent limitations. Second,
selection bias is possible. Third, frailty was not assessed.
Fourth, our study only reported in-hospital outcomes
without long-term follow-up. Fifth, potential improvement of quality of life after CTO PCI was not assessed. In
older patients, quality of life measures such as angina
pectoris relief may be more relevant than longevity. Fifth,
there was no clinical event adjudication by a clinical events
committee. Finally, all procedures were performed at highvolume, experienced PCI centers, limiting the generalizability of our findings to less experienced centers.

Conclusions
CTO PCI in octogenarians and nonagenarians is associated with lower technical and procedural success
rates and higher in-hospital MACE rates compared
with younger patients, likely due to higher prevalence of baseline comorbidities and higher CTO
lesion complexity.
A C K N O WL E D G M E N T S
Study data were collected and managed using Research
Electronic Data Capture (REDCap) electronic data capture tools hosted at the Minneapolis Heart Institute
Foundation (MHIF), Minneapolis, Minnesota. REDCap
is a secure, web-based application designed to support
data capture for research studies, providing: (1) an intuitive interface for validated data entry; (2) audit trails for
tracking data manipulation and export procedures;
(3) automated export procedures for seamless data downloads to common statistical packages; and (4) procedures
for importing data from external sources.
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